National Comprehensive Cancer Network

Educational Events & Programs

NCCN ACADEMY DATE > Wednesday, March 30, 2016

NCCN ACADEMY LOCATION > The Diplomat • Hollywood, Florida

Overview

Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.

Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.

Please check back often for additional updates regarding this program. If you have any questions, please contact Jennifer Tredwell.


Moderator:

Description: Cliff Goodman

Clifford Goodman, PhD
Senior Vice President
The Lewin Group

 

 

 

7:45 – 8:45 AM
Breakfast and Registration

8:50 – 8:55 AM
Welcome
C. Lyn Fitzgerald, MJ
Senior Vice President, U.S. & Global Development
National Comprehensive Cancer Network

9:00 – 10:45 AM
Module I:
Hot Topics in Cancer Care: Biosimilars, Specialty Pharmacy, Molecular Testing, Diagnostics, and Value
Panelists:
Matthew Fontana, MD
Chief Medical Officer, Pharmacy
HCSC

Andrew Krueger, MD
Medical Director
Accordant, CVS Health

Lee N. Newcomer, MD, MHA
Senior Vice President, Oncology, Genetics, and Women’s Health
UnitedHealthcare

Mark Oldroyd, JD
Senior Director, Payer Relations & Reimbursement
Foundation Medicine

William Yoon, PharmD, MBA
National Director, US Clinical Development and Medical Affairs
Sandoz Inc.

Martin J. Zagari, MD
Vice President, Global Health Economics
Amgen

10:45 – 10:55 AM
Break

11:00 AM – 12:30 PM
Module II:
Meet the NCCN Guideline Panel Experts
Panelists:
Robert W. Carlson, MD
Chief Executive Officer
Founding Chair, NCCN Guidelines Panel for Breast Cancer
National Comprehensive Cancer Network

William J. Gradishar, MD
Betsy Bramsen Professor of Breast Oncology
Director, Maggie Daley Center for Women`s Cancer Care
Director, Breast Medical Oncology          
Chair, NCCN Guidelines for Breast Cancer
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University

M. Dror Michaelson, MD PhD
Clinical Director, Urologic Oncology
Donald S. Kaufman Chair in Medical Oncology
Massachusetts General Hospital Cancer Center

Jerald P. Radich, MD
Member, Clinical Research Division
Professor, Medical Oncology Division
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Lee S. Schwartzberg, MD, FACP
Chief, Division of Hematology and Oncology
Panel Member, NCCN Guidelines for Myeloid Growth Factors
Panel Member, NCCN Guidelines for Breast Cancer
West Cancer Center
St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

12:30 – 1:10 PM
Lunch

1:15 – 2:55 PM
Module III:
Ensuring Access to Innovation
Panelists:
Joel W. Beetsch, PhD
Vice President, Patient Advocacy, Corporate Affairs
Celgene Corporation

Brian Garofalo
Managing Partner
Patient Alliances, LLC

Joan Levy, PhD
Vice President of Research
Multiple Myeloma Research Foundation

Christine MacCracken, MSHEd, BSN
Director, Patient Support
Janssen Office of the Chief Medical Officer
Janssen Pharmaceutical Companies of Johnson & Johnson

Lee N. Newcomer, MD, MHA
Senior Vice President, Oncology, Genetics, and Women’s Health
UnitedHealthcare

Michael Ybarra, MD
Senior Director
PhRMA

3:00 – 3:10 PM
Closing Remarks
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network

*All panelists to be announced.
*Subject to change.       


Program Location:

The Diplomat
3555 South Ocean Drive
Hollywood, Florida 33019

Tuition Information:

After 2.17.16

Academy Alumni

$895

Corporate Council Members

$1,195

Industry

$1,295

Ten people or more from the same company

$1,050

Accommodations:
NCCN has a limited number of rooms reserved at The Diplomat for the night of Tuesday, March 29, 2016. The room rate is $329.00 plus 11% tax (total $365.19).  Early booking is strongly suggested. Any requests received after Wednesday, February 17, 2016 will be contacted by NCCN to discuss availability. Learn more.

Airline Travel:
NCCN is proud to partner with Delta Air Lines and United Airlines to offer attendees of the NCCN 21st Annual Conference an opportunity to earn discounted airfares. Please see detailed reservations and ticketing information available here for each carrier.

Avis Rental Car:
Avis is the preferred rental car supplier for the NCCN 21st Annual Conference. Learn more.

Travel Agency:
Travel Leaders is the official travel agency for NCCN. William Lopez, NCCN’s exclusive agent, will make a reservation on your behalf. Learn more.


License NCCN Academy Video Modules!

Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.


Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.